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Pattern Visual Evoked Potential as a Predictor of 
Occlusion Therapy for Amblyopia
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Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea
Purpose: This study was conducted to investigate the role of the pattern visual evoked potential (pVEP) as 
a predictor of occlusion therapy for patients with strabismic, anisometropic, and isometropic amblyopia. The 
secondary aim was to compare the characteristics of pVEP between strabismic and anisometropic amblyopia. 
Methods: This retrospective comparative case series included 120 patients who had received occlusion 
therapy or a glasses prescription for correction of strabismic, anisometropic, and isometropic amblyopia (20 
patients had strabismic amblyopia, 41 patients had anisometropic amblyopia, and 59 patients had 
isometropic amblyopia). For each patient, the value of the P100 latency on pVEP at the time of the initial 
diagnosis of amblyopia was collected. Subsequently, the P100 latency was compared according to types of 
amblyopia. Fifty of 120 patients (7 patients with strabismic amblyopia, 21 patients with anisometropic 
amblyopia, and 22 patients with isometropic amblyopia) who were followed-up for longer than 6 months were 
divided into two groups based on the value of their P100 latency (Group 1, P100 latency 120 msec or less; 
Group 2, P100 latency longer than 120 msec.)  The amount of visual improvement after occlusion therapy 
or glasses was compared between two study groups. 
Results: The mean P100 latency was 119.7±25.2 msec in eyes with strabismic amblyopia and 111.9±17.8 
msec in eyes with non-strabismic (anisometropic or isometropic) amblyopia (p=0.213). In Group 1, the mean 
visual improvement after occlusion therapy or glasses was 3.69±2.14 lines on Dr. Hahn’s standard test 
chart; in Group 2, the mean improvement was 2.27±2.21 lines (p=0.023). 
Conclusions: The P100 latency on pVEP at the time of initial diagnosis was significantly related to the visual 
improvement after occlusion therapy or glasses in patients with strabismic, anisometropic, and isometropic 
amblyopia. Therefore, it was presumed that patients with a delayed P100 latency might have less visual 
improvement after occlusion therapy or glasses. In addition, there was no apparent difference in P100 
latency between patients with strabismic and non-strabismic (anisometropic or isometropic) amblyopia. 
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When a patient is diagnosed with amblyopia, the latent 
potential of vision improvement is very important when 
deciding on therapy. Recently, various attempts have been 
made to assess which factors present at the time of diagnosis 
reflect the final visual outcome after amblyopia treatment.1-6 
It has been reported that pattern reversal visual-evoked 
response acuity correlates with the best-corrected Snellen 
acuity in normal subjects.6,7 Increases in the amplitude on 
pattern visual evoked potential (pVEP) appear to reflect 
vision improvement during amblyopia treatment.3
Among patients with strabismic amblyopia, those with an 
eccentric fixation had a relatively delayed P100 latency and 
less vision improvement after 6 months of amblyopia 
treatment when compared with patients who had a central 
fixation,1 However, there are only a limited number of reports 
about pVEP in patients with anisometropic amblyopia.8
To investigate whether P100 latency could predict  visual 
outcomes in patients with functional amblyopia including not 
only strabismic but also anisometropic or isometropic 
amblyopia, patients were grouped by P100 latency on pVEP 
at the time of initial diagnosis, and visual improvement was 
compared after occlusion therapy between the two groups. 
Also, differences in P100 latency by type of amblyopia was 
sought.
Subjects and Methods
Amblyopia was classified as strabismic, anisometropic, 
isometropic (high bilateral refractive errors), visual 
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Table 1. Potentially amblyopiogenic refractive errors 
warranting optical corrections in infants and young 
children
Isometropic Diopters
  Astigmatism >2.50
  Hyperopia >4.50
Anisometropic
  Astigmatism >1.50
  Hyperopia >1.50
  Myopia >3.00
Table 2. Causes of amblyopia and number of patients by diagnosis (Group A : at least 6 months follow-up)
Unilateral No. of patients (Group A/Total) Bilateral
No. of patients 
(Group A/Total)
Strabismic 7/20 Visual deprivation (Isometropic) 22/59
Anisometorpic 21/41
Visual deprivation (blepharoptosis, hyphema) Out of criteria
Organic Out of criteria
deprivation, and organic according to the definitions proposed 
by the American Academy of Ophthalmology (Table 1).9 
When other compounding abnormalities with strabismus were 
present, unilateral hypermetropia greater than +4.50 diopters 
(D) with esotropia was classified as ‘strabismic’ and bilateral 
amblyopia with exotropia and hypermetropia greater than 
+4.50 D was classified as ‘isometropia’ according to the 
classification system established by von Noorden (Table 2).10 
A total of 120 cases with strabismic, anisometropic, and 
isometropic amblyopia (20 patients with strabismic 
amblyopia, 41 patients with anisometropic amblyopia, and 59 
patients with isometropic amblyopia) were included in this 
study from the patient database of our institution. Fifty of 
120 cases (7 patients with strabismic amblyopia, 21 patients 
with anisometropic amblyopia, and 22 patients with 
isometropic amblyopia) complied with occlusion therapy or 
glasses correction and were followed-up for longer than 6 
months. A retrospective, observational study was performed 
on patients with amblyopia who were younger than 14 years 
of age from March, 2001 to February, 2007. 
Amblyopia was diagnosed when the difference in visual 
acuity between two eyes was greater than two lines on Dr. 
Hahn’s standard test chart (unilateral amblyopia) or when the 
visual acuity of both eyes was less than the lower limit of 
age-matched visual acuity, namely, 20/50 for 3 year-olds and 
20/30 for 5 year-olds (bilateral amblyopia).9 
Patients with a history of any intraocular disease or 
surgery were excluded.  Only patients who complied with the 
occlusion therapy or with glasses correction and follow-up 
for longer than 6 months were analyzed to investigate 
whether the initial P100 latency was related to the outcome 
of occlusion therapy.
In brief, the refractive errors of each patient were 
completely corrected by cycloplegic refraction and patients 
were asked to wear accurately-prescribed glasses. Patients 
with unilateral amblyopia received part-time occlusion 
therapy for 6 hours per day and were followed-up by their 
physician as needed. Visual acuity was checked at each visit. 
The pVEP was performed within 2 weeks after the initial 
visit. For pVEP, a NIC 2015 visual stimulator, NIC HGA 
200 A amplifier, and NIC CA 1000 clinical averager 
(Nicolet, Co. USA) were used. From the patients’ clinical 
records, values of P100 latency were collected. 
For all 120 patients, the mean P100 latency was compared 
according to the types of amblyopia (strabismic amblyopia 
vs. non-strabismic amblyopia) and the dominance of eyes 
(dominant eye vs. non-dominant eye). We investigated the 
association between initial vision and initial P100 latency.
Fifty patients who complied with the occlusion therapy or 
glasses correction and who were followed-up for longer than 
6 months were divided into two groups by their P100 latency. 
The patients who did not show a delayed P100 latency (120 
msec or less) were placed in Group 1, and the others 
(delayed than 120 msec) were classified as Group 2. In the 
cases of bilateral amblyopia, the worst eye was selected for 
further analyses. Thirty-six patients (4 patients with 
strabismic amblyopia, 14 patients with anisometropic 
amblyopia, and 18 patients with isometropic amblyopia) were 
placed into Group 1, and 14 patients (3 patients with 
strabismic amblyopia, 7 patients with anisometropic 
amblyopia, and 4 patients with isometropic amblyopia) were 
assigned to Group 2. 
The amount of visual improvement after occlusion therapy 
or glasses was compared between the two study groups 
(Group 1 vs. Group 2) for the 50 subjects followed-up for 
at least 6 months from the initiation of occlusion therapy or 
glasses.
For these 50 patients, we investigated the association 
between age at the time of treatment initiation and the 
amount of vision improvement after occlusion therapy.
For statistical analysis, a 2-tailed paired Student’s t-test 
and correlation analysis using a Pearson correlation 
coefficient of SPSS 12.0 were used, and a P value of less 
than 0.05 was considered to be statistically significant. 
Results
Out of a total of 120 cases, 20 had strabismic amblyopia, 
41 had anisometropic amblyopia, and 59 had isometropic 
amblyopia. Unilateral amblyopia was present in 61 (50.83%) 
patients. The mean age was 7.56±2.37 (range, 2 to 13) years 
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Fig. 1. Vision improvement according to initial P100 latency. 
In patients with a P100 latency shorter than 120 msec, the 
vision was improved by 3.69±2.14 lines on Dr. Hahn’s 
standard test chart, and in patients with a P100 latency longer 
than 120 msec, the vision was improved by 2.27±2.21 lines 
(p=0.023).
old with 61 males and 59 females. The number of patients 
with at least 6 months of follow-up was 50 of 120 (41.67%). 
These patients had a mean follow-up of 3.01±1.69 (range, 0.5 
to 6) years. 
For all 120 patients, the mean P100 latency was 
119.7±25.2 (range, 91.8 to 176.1) msec for strabismic 
amblyopia and 111.9±17.8 (range, 76.2 to 173.4) msec for 
non-strabismic (anisometropic or isometropic) amblyopia, but 
this difference was not statistically significant (p=0.213). For 
the 61 patients with unilateral amblyopia, when the 
amblyopic eye was compared to the unaffected eye, the P100 
latency was delayed 8.45 msec in the strabismic amblyopic 
eye (p=0.577), and it was delayed by 0.66 msec in the 
anisometropic or isometropic amblyopic eye when compared 
to the non-amblyopic fellow eye, but these differences were 
not statistically significant (p=0.733). There was no 
statistically significant correlation between initial vision and 
initial P100 latency (r=-0.195, p=0.174).
For the 50 patients who were followed-up for longer than 
6 months, the amount of visual improvement after occlusion 
therapy was plotted according to the initial P100 latency 
(Figure 1). In Group 1 (patients with 120 msec or less P100 
latency), the patients’ vision improved by 3.69±2.14 lines on 
Dr. Hahn’s standard test chart; and in Group 2 (patients with 
P100 latency delay of more than 120 msec), vision improved 
by 2.27±2.21 lines (p=0.023). There was no statistically 
significant correlation between the age at the time of 
treatment initiation and the amount of visual improvement 
after occlusion therapy (r=0.038, p=0.794).
A comparison according to the types of amblyopia in each 
group was impossible due to a small sample size. 
Discussion
Attempts to find markers other than visual accuity to 
predict the effect of treatment for amblyopia have been 
sought. Latent potentials have been proposed as a marker to 
determine the amount of anticipated vision improvement 
upon initiation of treatment.1-6 Amblyopia is a type of 
developmental disorder that causes vision deterioration and is 
classified as strabismic, anisometropic, isometropic, stimulus 
deprivation, and organic-type. All types of amblyopia except 
organic-type are common causes of monocular amblyopia, 
and the prevalence of amblyopia is 1~5% in the general 
population.11,12 Amblyopia is caused by the dysfunction of the 
lateral geniculate body and the visual cortex, and the pVEP 
test, which measures electrical changes in the visual cortex 
in response to a retinal stimulus by light, shows abnormal 
changes.13-17 The pVEP is useful in the diagnosis of 
amblyopia and is used to follow changes in visual acuity 
during treatment. Generally, in amblyopia, the pVEP 
amplitude is decreased while the P100 latency is increased 
compared to normal eyes.6,18-22
To evaluate patients with amblyopia in whom it is difficult 
to determine visual acuity, a fixation test, optokinetic 
nystagmus, or VEP may be applied, and among these, VEP 
has the advantage of providing quantitative values.6,7,23-27 The 
use of a sweep VEP technique and interocular amplitude 
method of pVEP allow the diagnosis of amblyopia with 
greater sensitivity.2 
VEP could be applied not only to diagnose amblyopia, but 
also to monitor the effects of treatment and to allow 
prognosis of future treatment at the time of diagnosis.7 
According to Wildberger,18 VEP amplitude increases as 
visual acuity improves during treatment of amblyopia. 
According to Oner et al.3 who reported on 34 cases of 
anisometropic amblyopia treated with occlusion therapy for 6 
months, the level of visual improvement was proportional to 
the increase in the P100 amplitude thus proving the 
usefulness of pVEP for follow-up of amblyopia treatments. 
Ridder et al.2 have reported that the visual acuity predicted 
prior to amblyopia treatment by sweep VEP is closely related 
to the Snellen visual acuity after amblyopia treatment, and 
that sweep acuity is a good predictor of visual acuity after 
treatment.
According to Iliakis et al.1 who investigated 60 cases of 
strabismic amblyopia, the P100 latency of patients with 
strabismus and eccentric fixation was greater than the P100 
in those with strabismus and central fixation, and their 
prognosis was worse after occlusion therapy. Therefore, the 
P100 latency at the time of the initial diagnosis could be 
applied as a factor to predict the outcome of amblyopia 
treatment; however, the above study made comparisons 
between those with eccentric fixation and those with central 
fixation, so it is necessary to confirm whether these results 
could also be applied to other types of amblyopia including 
anisometropic amblyopia.1
In addition, during the process of the division of the 
patient groups, other standards (fixation pattern) other than 
P100 latency were included, so a selection bias may have 
been present. In the above experiments, the follow-up period 
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of occlusion therapy was 6 months, which is rather short to 
evaluate  vision improvement after amblyopia treatment. To 
assess target vision after occlusion therapy more accurately, 
longer periods of follow-up after treatment are necessary. 
We found no significant difference in the P100 latency 
pattern between strabismic amblyopia and non-strabismic 
(anisometropic or isometropic) amblyopia. The amblyopia 
patient group which included patients with strabismic, 
anisometropic, and isometropic amblyopia followed-up for 
longer than 6 months (average follow up period: 3.01 years) 
were classified according to the P100 latency at the time of 
the initial diagnosis, and the level of vision improvement 
after amblyopia treatment and the visual acuity at the final 
visit were compared. A linear correlation between initial 
P100 latency and vision improvement was not detected, but 
a longer P100 latency was related to a decrease in final visual 
acuity, and in cases with longer than 120 msec of P100 
latency, a statistically significant reduction in final visual 
acuity was observed; however, in VEP testing, cases with a 
P100 latency shorter than 120 msec are more common, so 
in order to apply VEP as a predictor of amblyopia treatment, 
more studies with substantially larger numbers of subjects are 
required. 
In patients with functional amblyopia, P100 latency 
showed similar values in eyes with strabismic amblyopia and 
non-strabismic (anisometropic or isometropic) amblyopia, and 
P100 latency on pVEP at the time of initial diagnosis was 
related to vision improvement after occlusion therapy. The 
initial P100 latency can therefore be used to predict outcomes 
after occlusion therapy for functional amblyopia.
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